Literature DB >> 8639545

Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation.

E Z Baum1, M M Siegel, G A Bebernitz, J D Hulmes, L Sridharan, L Sun, K Tabei, S H Johnston, M J Wildey, J Nygaard, T R Jones, Y Gluzman.   

Abstract

A symmetrically substituted disulfide compound, CL13933, was identified as a potent inhibitor of human cytomegalovirus UL80 protease. Two types of inhibited protease were observed, depending on inhibitor concentration. At high concentrations, CL13933 formed a covalent adduct with the protease on Cys residues. At lower concentrations, this compound induced specific intramolecular disulfide formation between Cys84 and Cys87, and between Cys138 and Cys161. In contrast, Cys202 did not form disulfide bonds. Inhibition was reversed upon reduction of the protease. Each of the five cysteines of the UL80 protease was individually mutated to Ala. Each of the mutant proteases retained enzymatic activity, but mutants C138A and C161A were resistant to inhibition by CL13933, suggesting that disulfide bond formation between Cys138 and Cys161 is responsible for inhibition. This disulfide is apparently not induced by air oxidation. Examination of the CL13933 loading patterns of wild type and the five mutant proteases by mass spectrometry revealed that residues Cys87, Cys138, and Cys161 react with CL13933, and that the disulfide pair partner of each (Cys84, Cys161, and Cys138, respectively) is able to displace the compound via thiol-disulfide exchange. The possible significance of these reactive thiols in the protease is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639545     DOI: 10.1021/bi952996+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  Protease inhibitors as antiviral agents.

Authors:  A K Patick; K E Potts
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

2.  Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins.

Authors:  David R Morcock; James A Thomas; Tracy D Gagliardi; Robert J Gorelick; J David Roser; Elena N Chertova; Julian W Bess; David E Ott; Quentin J Sattentau; Ines Frank; Melissa Pope; Jeffrey D Lifson; Louis E Henderson; Bruce J Crise
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Initial characterization of autoprocessing and active-center mutants of CMV proteinase.

Authors:  S W Snyder; R P Edalji; F G Lindh; K A Walter; L Solomon; S Pratt; K Steffy; T F Holzman
Journal:  J Protein Chem       Date:  1996-11

4.  Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine.

Authors:  Kaitlin R Hulce; Priyadarshini Jaishankar; Gregory M Lee; Markus-Frederik Bohn; Emily J Connelly; Kristin Wucherer; Chayanid Ongpipattanakul; Regan F Volk; Shih-Wei Chuo; Michelle R Arkin; Adam R Renslo; Charles S Craik
Journal:  Cell Chem Biol       Date:  2022-03-31       Impact factor: 9.039

5.  Synthesis and redox-enzyme modulation by amino-1,4-dihydro-benzo[d][1,2]dithiine derivatives.

Authors:  Sandraliz Espinosa; Melissa Solivan; Cornelis P Vlaar
Journal:  Tetrahedron Lett       Date:  2009-06-24       Impact factor: 2.415

6.  N-acetylpenicillamine inhibits the replication of porcine reproductive and respiratory syndrome virus in vitro.

Authors:  Yunbo Jiang; Liurong Fang; Rui Luo; Shaobo Xiao; Huanchun Chen
Journal:  Vet Res Commun       Date:  2010-07-31       Impact factor: 2.459

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.